Segall Bryant & Hamill, LLC Neogenomics Inc Transaction History

Segall Bryant & Hamill, LLC

  • $6.35 Billion
  • Q1 2025

A detailed history of Segall Bryant & Hamill, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 2,350,746 shares of NEO stock, worth $15.2 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,350,746
Previous 2,113,822 11.21%
Holding current value
$15.2 Million
Previous $34.8 Million 35.96%
% of portfolio
0.35%
Previous 0.49%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
BUY
$9.09 - $18.61 $2.15 Million - $4.41 Million
236,924 Added 11.21%
2,350,746 $22.3 Million
Q4 2024

Feb 11, 2025
BUY
$13.0 - $18.43 $2.87 Million - $4.06 Million
220,415 Added 11.64%
2,113,822 $34.8 Million
Q3 2024

Nov 08, 2024
BUY
$13.4 - $17.73 $10.2 Million - $13.5 Million
759,524 Added 66.98%
1,893,407 $27.9 Million
Q2 2024

Aug 14, 2024
SELL
$13.01 - $15.77 $2.58 Million - $3.12 Million
-198,098 Reduced 14.87%
1,133,883 $15.7 Million
Q1 2024

May 15, 2024
SELL
$14.06 - $16.79 $357,911 - $427,406
-25,456 Reduced 1.88%
1,331,981 $20.9 Million
Q4 2023

Feb 14, 2024
SELL
$11.67 - $20.73 $25,510 - $45,315
-2,186 Reduced 0.16%
1,357,437 $22 Million
Q3 2023

Nov 09, 2023
BUY
$12.15 - $17.85 $225,370 - $331,099
18,549 Added 1.38%
1,359,623 $16.7 Million
Q2 2023

Aug 11, 2023
BUY
$14.1 - $19.83 $3.1 Million - $4.36 Million
220,018 Added 19.63%
1,341,074 $21.6 Million
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $475,797 - $1.02 Million
52,343 Added 4.9%
1,121,056 $19.5 Million
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $6.89 Million - $12.9 Million
1,068,713 New
1,068,713 $9.87 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $8.74 Million - $14.4 Million
1,111,874 New
1,111,874 $9.58 Million
Q4 2021

Feb 14, 2022
SELL
$30.49 - $48.49 $1.21 Million - $1.92 Million
-39,654 Closed
0 $0
Q3 2021

Nov 03, 2021
SELL
$41.66 - $52.52 $1.68 Million - $2.12 Million
-40,345 Reduced 50.43%
39,654 $1.91 Million
Q2 2021

Aug 12, 2021
SELL
$36.62 - $51.69 $1.02 Million - $1.44 Million
-27,821 Reduced 25.8%
79,999 $3.61 Million
Q1 2021

May 13, 2021
SELL
$41.56 - $59.88 $211,041 - $304,070
-5,078 Reduced 4.5%
107,820 $5.2 Million
Q4 2020

Feb 12, 2021
SELL
$36.08 - $56.47 $372,598 - $583,165
-10,327 Reduced 8.38%
112,898 $6.08 Million
Q3 2020

Nov 13, 2020
BUY
$33.26 - $40.48 $87,773 - $106,826
2,639 Added 2.19%
123,225 $4.55 Million
Q2 2020

Aug 14, 2020
SELL
$24.21 - $31.02 $293,764 - $376,396
-12,134 Reduced 9.14%
120,586 $3.74 Million
Q1 2020

May 14, 2020
BUY
$20.5 - $34.53 $162,442 - $273,615
7,924 Added 6.35%
132,720 $3.66 Million
Q4 2019

Feb 11, 2020
SELL
$18.96 - $29.84 $1.66 Million - $2.62 Million
-87,706 Reduced 41.27%
124,796 $3.65 Million
Q3 2019

Nov 12, 2019
SELL
$19.12 - $26.24 $39,731 - $54,526
-2,078 Reduced 0.97%
212,502 $4.06 Million
Q2 2019

Aug 14, 2019
SELL
$19.57 - $24.1 $352,436 - $434,016
-18,009 Reduced 7.74%
214,580 $0
Q1 2019

May 15, 2019
SELL
$12.14 - $20.46 $441,665 - $744,355
-36,381 Reduced 13.53%
232,589 $0
Q4 2018

Feb 15, 2019
SELL
$11.24 - $18.5 $263,240 - $433,270
-23,420 Reduced 8.01%
268,970 $3.39 Million
Q3 2018

Nov 14, 2018
SELL
$12.5 - $15.38 $753,425 - $927,014
-60,274 Reduced 17.09%
292,390 $0
Q2 2018

Aug 08, 2018
SELL
$7.99 - $14.05 $708,840 - $1.25 Million
-88,716 Reduced 20.1%
352,664 $0
Q1 2018

May 16, 2018
BUY
$7.23 - $8.76 $50,262 - $60,899
6,952 Added 1.6%
441,380 $0
Q4 2017

Feb 15, 2018
BUY
$8.02 - $11.18 $484,087 - $674,824
60,360 Added 16.14%
434,428 $0
Q3 2017

Nov 14, 2017
BUY
$9.11 - $11.26 $3.41 Million - $4.21 Million
374,068
374,068 $0

Others Institutions Holding NEO

# of Institutions
281
Shares Held
127M
Call Options Held
942K
Put Options Held
172K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $813M
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email